Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors [Phase 1]
Phase 1 trial evaluating cabozantinib S-malate in younger patients with recurrent or refractory solid tumors; status completed with results …
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets [Phase 2]
Phase 2 trial evaluating troriluzole or placebo plus ipilimumab and nivolumab in metastatic brain metastases from melanoma has been terminat…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: TIL and Anti-PD1 in Metastatic Melanoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating tumor-infiltrating lymphocytes (TIL) and anti-PD1 therapy in metastatic melanoma; current status unknown with tox…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma [Phase 1]
Phase 1 trial assessing trigriluzole in combination with nivolumab and pembrolizumab for various metastatic or unresectable solid tumors and…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab [Phase 1, Phase 2]
Phase 1/2 trial of CD40 agonist APX005M (sotigalimab) with nivolumab in cancer including metastatic non-small cell lung cancer and melanoma …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma [Phase 4]
Phase 4 trial updating HD IL-2 plus ipilimumab in metastatic melanoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: FLX475 in Combination With Ipilimumab in Advanced Melanoma [Phase 2]
Phase 2 trial of FLX475 in combination with ipilimumab in advanced melanoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation. [Phase 3]
A phase 3 trial is evaluating adjuvant combination therapy with encorafenib and binimetinib for high-risk stage II melanoma with a BRAF muta…
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: Using MC1R Genotype to Impact Melanoma Risk Behavior [NA]
Completed clinical trial evaluating whether MC1R genotype information can influence melanoma risk-related behaviors. Results were posted in …
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating PV-10 in combination with pembrolizumab for metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Nivolumab Plus Radiotherapy in Advanced Melanoma [Phase 2]
Phase 2 clinical trial update of nivolumab plus radiotherapy in advanced melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update for HBI-8000 in combination with nivolumab across melanoma, renal cell carcinoma, and non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists [Phase 1, Phase 2]
Phase I/II trial evaluating LPV7 vaccine with TLR agonists in melanoma showed completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents [Phase 1, Phase 2]
Phase 1/2 trial evaluating OR2805, a anti-CD163 monoclonal antibody, alone and with anticancer agents for solid tumors, with unspecified sta…
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC [Phase 1, Phase 2]
Phase 1/2 trial evaluating MK-3475 (pembrolizumab) in combination with stereotactic body radiotherapy in patients with metastatic melanoma o…
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: PD-1 Antibody Tislelizumab Combined With Dacarbazine in the Treatment of Advanced Melanoma [Phase 2]
Phase 2 trial update evaluating tislelizumab combined with dacarbazine for advanced melanoma.
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma [Phase 2]
Phase 2 clinical trial update evaluating regorafenib in patients with pretreatment advanced melanoma (stages III and IV).
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma [Phase 1, Phase 2]
A clinical trial investigating imatinib mesylate in combination with pembrolizumab for melanoma in Phase 1/2; status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type Melanoma [Phase 2]
Phase 2 trial updating trametinib in patients with BRAFV600 wild-type advanced pretreated melanoma has been completed.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: INCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors. [Phase 1]
Phase 1 trial evaluating INCB039110 in combination with dabrafenib and trametinib in patients with BRAF-mutant melanoma and other solid tumo…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma [Phase 3]
Phase 3 trial evaluating the efficacy and safety of BCD-201 in combination with Keytruda for advanced melanoma is ongoing with an unknown st…
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma [Phase 2]
A Phase 2 trial evaluating the combination of MAPK-targeted therapy with pembrolizumab for metastatic melanoma has posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma [Phase 2]
A Phase 2 clinical trial update evaluating neoadjuvant dabrafenib, trametinib and/or pembrolizumab in BRAF-mutant resectable stage III melan…
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of VE800 in combination with nivolumab has completed enrollment and posted results for selected advanced cancers. T…
-
CLINICAL_TRIALS trial_result · 2023-08-28Clinical Trial Update: An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread [Phase 1, Phase 2]
Phase 1/2 trial investigating BMS-986205 with nivolumab alone and with nivolumab plus ipilimumab in advanced cancers, including melanoma and…